Targeted therapy for esophagogastric cancers: a review.

Onco Targets Ther · 2012 · PMC3377432 · PMID 22719211

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

There was a nonsignificant trend towards improved outcome in patients with high EGFR expression compared with low EGFR expression (TTP 5.1 months versus 1.8 months and OS 7.8 months versus 2.8 months). 73 In all the trials of oral TKIs as monotherapy or combination therapy, there has been no significant additional toxicity associated with the use of TKIs.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.